ECM Weekly (29th August 2021) - Imeik, Helenās, Jenscare, Dingdang, Simplex, Hyundai Heavy
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
567 Views
AmbioPharm (ęåå¶čÆ) Pre-IPO: Peptide CDMO Leader Turning Licensor
AmbioPharm is a global leader in the peptide CDMO business and will further monetizing its expertise by collaborating with partners to develop...
1.1k Views
Pre-IPO Ambio Pharmaceuticals - The Particularity of Peptide Drugs, the Strength and the Concerns
The article mainly analyzed Ambio Pharmaceuticals inĀ terms of theĀ particularity of peptide drugs & industry characteristics, the strength of its...
714 Views